Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Analysis of entities with the lowest risk in crypto, plus how to interpret liquidity, use case maturity, and developer activity for safer bets.
28,397 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
PepsiCo stock faces a fresh price prediction this popular blue-chip dividend stock, with an upside case built on inte...
Bumble delivered a beat on Q4 2025 revenue as it unveiled Bee, an AI dating concierge. The move coincided with a dram...
Retirees cling to a low-cost dividend ETF that advisors often push, yet most seniors can’t recall the ticker. This re...
Trump stalls a landmark affordable housing package, linking it to a national voter ID push. The standoff unsettles bu...
Costco stock sits in the mid-700s as of July 2026. Analysts weigh whether a $2,000 target by 2030 is plausible, consi...
A pastor on The Ramsey Show recounts a pivotal moment in 2015 when Dave Ramsey urged him to face painful memories. Th...
Dawn Kernicky, senior vice president of late-stage default at ServiceMac, champions a people-first approach to mortga...
A surge of progressive candidates backed by a Mamdani slate toppled two Democratic incumbents in a New York primary, ...
A sudden political pivot put South Carolina in the spotlight as former President Trump floated Darline Graham Nordone...
NVIDIA reports strong quarterly results, but the bigger story is a catastrophic GPU shortage. Real-time trackers show...
Rent prices dropping nationwide are reshaping tenant leverage as supply catches up with demand. This report flags whe...